dactinomycin and vx680

dactinomycin has been researched along with vx680 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Campbel, J; Higgins, M; Lain, S; Lane, DP; Rao, B; Thompson, AM; van Leeuwen, IM	1

Other Studies

1 other study(ies) available for dactinomycin and vx680

Article	Year
Evaluation of an Actinomycin D/VX-680 aurora kinase inhibitor combination in p53-based cyclotherapy. Oncotarget, 2010, Volume: 1, Issue:7 Topics: Aneugens; Aneuploidy; Antineoplastic Combined Chemotherapy Protocols; Aurora Kinases; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cytoprotection; Dactinomycin; Dose-Response Relationship, Drug; Gene Knockout Techniques; Genes, p53; HCT116 Cells; Humans; Imidazoles; Neoplasms; Piperazines; Protein Serine-Threonine Kinases	2010

Article

Year

Evaluation of an Actinomycin D/VX-680 aurora kinase inhibitor combination in p53-based cyclotherapy.

Oncotarget, 2010, Volume: 1, Issue:7

Topics: Aneugens; Aneuploidy; Antineoplastic Combined Chemotherapy Protocols; Aurora Kinases; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cytoprotection; Dactinomycin; Dose-Response Relationship, Drug; Gene Knockout Techniques; Genes, p53; HCT116 Cells; Humans; Imidazoles; Neoplasms; Piperazines; Protein Serine-Threonine Kinases

2010